disease interaction of diabetes mellitus type-2 with familial nephrolithiasis
Jump to navigation
Jump to search
Introduction
Interactions:
- in patients with diabetes mellitus type 2, SGLT-2 inhibitors associated with lower risk for kidney stones vs GLP-1 receptor agonists or DPP-4 inhibitors[1]
More general terms
References
- ↑ 1.0 1.1 Paik JM et al. Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes. JAMA Intern Med 2024 Jan 29; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38285598 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2814491